Mats Jerkeman
0000-0003-4509-6707
5 papers found
Refreshing results…
Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL
Tackling Mantle Cell Lymphoma in Europe
Pre‐treatment health‐related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA‐BERIT) experience
Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B‐cell lymphoma: a Swedish lymphoma register study
Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma
Missing publications? Search for publications with a matching author name.